BERDAZIMER

BERDAZIMER was reported 95 times

BERDAZIMER is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPLICATION SITE ECZEMA 4 0.0460
1 APPLICATION SITE NODULE 2 0.0146
2 APPLICATION SITE INFLAMMATION 5 0.0036
3 APPLICATION SITE DERMATITIS 3 0.0032
4 APPLICATION SITE PUSTULES 1 0.0027
5 APPLICATION SITE PAIN 46 0.0021
6 APPLICATION SITE DISCOLOURATION 8 0.0020
7 MOLLUSCUM CONTAGIOSUM 1 0.0019
8 APPLICATION SITE SCAB 4 0.0019
9 APPLICATION SITE EXFOLIATION 6 0.0015
10 APPLICATION SITE VESICLES 9 0.0014
11 APPLICATION SITE ERYTHEMA 31 0.0012
12 SKIN TEXTURE ABNORMAL 1 0.0010
13 APPLICATION SITE DISCHARGE 1 0.0009
14 APPLICATION SITE HYPERSENSITIVITY 1 0.0008
15 APPLICATION SITE SWELLING 4 0.0008
16 APPLICATION SITE EROSION 1 0.0008
17 APPLICATION SITE IRRITATION 8 0.0006
18 APPLICATION SITE BURN 3 0.0006
19 APPLICATION SITE RASH 8 0.0006
20 APPLICATION SITE DISCOMFORT 1 0.0006
21 APPLICATION SITE PRURITUS 12 0.0005
22 APPLICATION SITE URTICARIA 1 0.0004
23 SKIN EROSION 1 0.0003
24 APPLICATION SITE DRYNESS 1 0.0003
25 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
26 PRODUCT PREPARATION ERROR 2 0.0001
27 DERMATITIS CONTACT 1 0.0001
28 PRODUCT PHYSICAL ISSUE 1 0.0000
29 PRODUCT ADMINISTRATION ERROR 1 0.0000
30 SKIN LESION 1 0.0000
31 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
32 RASH MACULAR 1 0.0000
33 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
34 POLLAKIURIA 1 0.0000
35 SKIN DISCOLOURATION 1 0.0000
36 RASH PRURITIC 1 0.0000
37 PRODUCT STORAGE ERROR 1 0.0000
38 PRODUCT QUALITY ISSUE 1 0.0000
39 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
40 RASH 1 0.0000